Brand Name(s) in US
ChemicalBook > CAS DataBase List > Penicillin G

Penicillin G

Brand Name(s) in US
Product Name
Penicillin G
CAS No.
61-33-6
Chemical Name
Penicillin G
Synonyms
BENZYLPENICILLIN;PENICILLIN G POTASSIUM;BENZYLPENICILLIN POTASSIUM;PENICILIN;pencilling;Allpen;cilopen;galofak;Ursopen;cilloral
CBNumber
CB1211939
Molecular Formula
C16H18N2O4S
Formula Weight
334.39
MOL File
61-33-6.mol
More
Less

Penicillin G Property

Melting point:
82-83 °C
Boiling point:
663.3±55.0 °C(Predicted)
alpha 
D +282° (ethanol)
Density 
1.2729 (rough estimate)
refractive index 
1.6930 (estimate)
storage temp. 
2-8°C
solubility 
H2O: 100 mg/mL
form 
powder
pka
2.45±0.50(Predicted)
color 
Crystals
Water Solubility 
2.675g/L(25 ºC)
CAS DataBase Reference
61-33-6(CAS DataBase Reference)
EPA Substance Registry System
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)- (61-33-6)
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
42/43
Safety Statements 
36/37
WGK Germany 
2
RTECS 
XH9700000
10-23
HS Code 
32041900
Hazardous Substances Data
61-33-6(Hazardous Substances Data)
Toxicity
LD50 orl-rat: 8 g/kg ANTCAO 12,249,62
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H317May cause an allergic skin reaction

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P272Contaminated work clothing should not be allowed out of the workplace.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P333+P313IF SKIN irritation or rash occurs: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
Y0001889
Product name
Benzylpenicillin for system suitability
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
y0001889
Price
$161
Updated
2023/06/20
American Custom Chemicals Corporation
Product number
API0003779
Product name
PENICILLIN-G
Purity
95.00%
Packaging
100MG
Price
$885.31
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0003779
Product name
PENICILLIN-G
Purity
95.00%
Packaging
500MG
Price
$1127.86
Updated
2021/12/16
More
Less

Penicillin G Chemical Properties,Usage,Production

Brand Name(s) in US

Penicillin G potassium or sodium: Many brands
Penicillin G benzathine: Benza-Pen, and other names
Penicillin G, Procaine: Generic
Penicillin V: Pen-Vee

Description

Penicillin was the first natural antibiotic used to treat bacterial infections and continues to be one of the most important antibiotics.The name comes from the fungus genus Penicillium from which it was isolated. Penicillus is Latin for brush and refers to the brushlike appearance of filamentous Penicillium species.Species of this genus are quite common and appear as the bluish-green mold that appears on aged bread, fruit, and cheese. The term penicillin is a generic term that refers to a number of antibiotic compounds with the same basic structure. Therefore it is more appropriate to speak of penicillins than of penicillin.
The general penicillin structure consists of a β-lactam ring and thiazolidine ring fused together with a peptide bonded to a variable R group. Penicillin belongs to a group of compounds called β-lactam antibiotics. This in turn inhibits the formation of peptidoglycan cross-links in bacteria cell walls.

History

The discovery of penicillin is generally credited to Alexander Fleming (1881 1955) in 1928, but the development of penicillin as an antibiotic took place sporadically over the last decades of the 19th century and first half of the 20th century. Mass production of penicillin by U.S.firms started in 1943,and it was used immediately to treat wounded soldiers. Penicillin reduced suff ering, prevented amputations,cured pneumonia,and saved thousands of lives during the war and was hailed as a miracle drug. The United States increased production throughout the war years and after the war widespread civilian use commenced. Fleming, Florey,and Chain shared the Nobel Prize in physiology or medicine in 1945 for their work on penicillin.

Uses

Benzylpenicillin is the drug of choice for infections caused by sensitive organisms. This includes streptococci infections (except enterococci), gonococci, and meningococci that do not produce beta-lactam anaerobes. Benzylpenicillin is used for croupous and focal pneumonia, skin infections, soft tissue and mucous membranes, periotonitis, cystisis, syphilis, diphtheria, and other infectious diseases. Synonyms of this drug are megacillin,

Uses

Penicillin is an antimicrobial agent.

Uses

Antibacterial.

Indications

Benzylpenicillin or penicillin G has a narrow antimicrobial spectrum. It is active with respect to Gram-positive bacteria (staphylococcus, streptococcus, and pneumococci), causative agent of diphtheria, and anthrax bacillus. Gram-negative bacteria are resistant to it. Benzylpenicillin is broken down by stomach acid and destroyed by staphylococcus penicillinase.

Definition

ChEBI: Benzylpenicillin is a penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. It has a role as an antibacterial drug, an epitope and a drug allergen. It is a penicillin allergen and a penicillin. It is a conjugate acid of a benzylpenicillin(1-).

brand name

Pentids (Apothecon); Pfizerpen (Pfizer).

Antimicrobial activity

It has intrinsic activity against almost all Grampositive pathogens, but is no longer effective against most staphylococci. Most species of streptococci are susceptible, including group B streptococci, an important cause of neonatal infections. Enterococci are more resistant than streptococci. Other susceptible Gram-positive organisms include non-β-lactamase-producing Bacillus anthracis and Listeria monocytogenes.
The spirochetes Borrelia burgdorferi and Treponema pallidum are also susceptible.
The aerobic Gram-negative cocci Neisseria gonorrhoeae and N. meningitidis were initially highly susceptible to benzylpenicillin, but β-lactamase-producing strains of gonococci are now common. H. influenzae and Moraxella catarrhalis are usually resistant due to β-lactamase production. The Enterobacteriaceae and most other aerobic Gram-negative bacilli are resistant, as a result of β-lactamase production or the impermeability of the bacterial cell wall. Other resistant organisms include mycobacteria, mycoplasmas, Nocardia spp., rickettsiae and chlamydiae.
Anaerobic Gram-positive cocci are susceptible in the absence of β-lactamase production. Most clostridia strains are susceptible, but resistance can be observed. Anaerobic Gram-negative bacilli vary in their sensitivity: the Bacteroides fragilis group is resistant as the result of β-lactamase action, but many Prevotella and Fusobacterium spp. are susceptible.
Benzylpenicillin exhibits concentration-dependent bactericidal activity against growing organisms. Killing of highly susceptible Gram-positive cocci seldom proceeds to eradication, with measurable numbers of survivors (‘persisters’), which are fully susceptible on retesting. Some strains of streptococci (including group B) and pneumococci show very large numbers of persisters, resulting in a large difference between the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC), a phenomenon known as ‘tolerance’.
Combination with aminoglycosides results in pronounced bactericidal synergy.

Acquired resistance

Staph. aureus was originally highly susceptible to benzylpenicillin, but at least 85–90% of clinical isolates are now β-lactamase-producing strains. Most clinical isolates of coagulase- negative staphylococci are also resistant. β-Lactamaseproducing strains of E. faecalis produce an enzyme identical to staphylococcal penicillinases, but these strains are increasingly uncommon. The emergence of penicillin-resistant staphylococci, enterococci and pneumococci, due to the acquisition of mosaic PBPs with decreased binding affinity for penicillin, has been described worldwide. Most strains of penicillin- resistant Gram-positive clinical isolates also demonstrate reduced susceptibility to other β-lactam agents but, in rare cases, cross-resistance is not seen for all cephalosporins.
Strains of N. gonorrhoeae for which the MIC of benzylpenicillin increased from 0.06 mg/L to >2 mg/L appeared in the 1970s, as the result of the production of modified PBPs with reduced affinity for β-lactam antibiotics; fully resistant strains producing TEM-1 β-lactamase also emerged. Currently penicillin resistance occurs in more than 60% of isolates in some parts of the world.

Contact allergens

Benzyl penicillin is actually used only intravenously. It was formerly a frequent cause of contact allergy in health care workers. Facial contact dermatitis was recently reported in a nurse.

Pharmacokinetics

Oral absorption: 2–25%
Cmax 0.6 g intramuscular: 12 mg/L
3 g intravenous (3–5 min): 400 mg/L
Plasma half-life: 0.5 h
Volume of distribution: 0.2–0.7 L/kg
Plasma protein binding: 60%
Absorption
Benzylpenicillin is unstable in acid and destroyed in the stomach. As a result, plasma concentrations obtained after oral administration are variable, and are depressed by administration with food. It is absorbed from serous cavities, joints and the subarachnoid space. It is not absorbed following applications to the skin, which should be avoided because of the likelihood of sensitization.
Distribution
The drug is widely distributed in most tissues and body fluids. Highest levels are found in the kidney, with lower levels in the liver, skin and intestines. Low concentrations appear in saliva and in maternal milk. It does not enter uninflamed bone or the CSF. Its entry is limited by its low pKa (2.6), which results in its almost complete ionization and very low lipid–water partition coefficient at pH 7.4. When the meninges are inflamed, the concentrations obtained in CSF are around 5% of the plasma level. In uremia, accumulated organic acids may enter the CSF and compete for transport of penicillin, causing the concentration to reach convulsive levels.
It diffuses into wound exudates and experimental transudates when the serum level is high, and enters glandular secretions and the fetal circulation, whence it is excreted in increased concentrations into the amniotic fluid.
Metabolism and excretion
About 40% is metabolized in the liver, mainly to penicilloic acid. After oral dosing, unabsorbed drug is largely degraded by colonic bacteria and little activity remains in the feces. Concentrations 2–4 times those of the plasma are found in bile, but 60–90% is excreted in the urine, largely in the first hour. Probenecid causes a doubling of the peak concentration and prolongation of the plasma half-life. Other drugs, including aspirin, sulfonamides and some non-steroidal anti-inflammatory drugs and diuretics, may prolong the half-life.

Clinical Use

Serious infections caused by streptococci (including Str. pneumoniae)
other than meningitis caused by penicillin-resistant pneumococci
Serious infections caused by susceptible strains of staphylococci
Meningococcal septicemia and meningitis
Gonococcal infections caused by susceptible strains
Syphilis (including neurosyphilis) and other spirochetal infections
Anthrax
Actinomycosis
Clostridial infections
Diphtheria (adjunctive therapy to antitoxin and for prevention of carrier state) Infections with other susceptible organisms, including Listeria
monocytogenes, Pasteurella multocida, Erysipelothrix insidiosa and Fusobacterium

Clinical Use

For years, the most popular penicillin has been penicillin G,or benzylpenicillin. In fact, with the exception of patients allergicto it, penicillin G remains the agent of choice for thetreatment of more different kinds of bacterial infection thanany other antibiotic. It was first made available as the watersolublesalts of potassium, sodium, and calcium. These saltsof penicillin are inactivated by the gastric juice and are noteffective when administered orally unless antacids, such ascalcium carbonate, aluminum hydroxide, and magnesiumtrisilicate; or a strong buffer, such as sodium citrate, isadded. Also, because penicillin is absorbed poorly from the intestinal tract, oral doses must be very large, about fivetimes the amount necessary with parenteral administration.Only after the production of penicillin had increased enoughto make low-priced penicillin available did the oral dosageforms become popular. The water-soluble potassium andsodium salts are used orally and parenterally to achieve highplasma concentrations of penicillin G rapidly. The morewater-soluble potassium salt usually is preferred when largedoses are required. Situations in which hyperkalemia is adanger, however, as in renal failure, require use of thesodium salt; the potassium salt is preferred for patients onsalt-free diets or with congestive heart conditions.

Side effects

Benzylpenicillin has low toxicity, except for the nervous system (into which it does not normally penetrate), where it is one of the most active convulsants among the β-lactam agents. Excessively high intravenous doses may induce convulsions and intrathecal doses should never exceed 12 mg (20 000 units) in adults or 3 mg (5000 units) in a child as a single daily dose. Inadvertent intravascular administration, especially direct injection into arteries, can cause serious neurotoxic damage, including hyperreflexia, myoclonic twitches, seizures and coma.
Massive intravenous doses of the sodium or potassium salts can lead to severe or fatal electrolyte disturbances. In patients treated with large doses of the potassium salt (60 g or more per day), hyponatremia, hyperkalemia and metabolic acidosis can develop.
Thrombocytopenia and platelet dysfunction resulting in coagulopathy and involving several different mechanisms have been described. Neutropenia associated with fever and allergic rash appears to be related to total dose, usually in excess of 90 g. Although it can be very severe, in most patients recovery occurs within a few days of withdrawal of treatment. Large doses (24 g [40 megaunits] per day intravenously), or smaller doses given to patients with impaired renal function, may interfere with platelet function.
The most dramatic untoward response is anaphylactic shock due to allergy . In addition to the generalized allergic reactions, particular organs may be damaged by a variety of immunological mechanisms. Hemolytic anemia occurs only in patients who have been treated previously with penicillin, and again receive a prolonged course of large doses (commonly 12 g per day). Reversible hemolysis is due to the action of anti-penicillin immunoglobulin G (IgG) on cells that have absorbed the antibiotic. Nephritis, resulting in dysuria, pyuria, proteinuria, azotemia and histological evidence of nephritis of allergic origin, is only rarely seen, usually in patients receiving large doses (12–36 g [20–60 megaunits] per day).

Safety Profile

Poison by ingestion, intravenous,intracerebral, intraspinal, subcutaneous, and possibly otherroutes. Human (child) systemic effects by parenteral route:changes in cochlear (inner ear) structure or function,convulsions, and dyspnea. Questionable carcin

Drug interactions

Potentially hazardous interactions with other drugs
Reduced excretion of methotrexate.

Metabolism

Benzylpenicillin is metabolised to a limited extent and the penicilloic acid derivative has been recovered in the urine. Benzylpenicillin is rapidly excreted in the urine; about 20% of an oral dose appears unchanged in the urine; about 60-90% of an IM dose of benzylpenicillin undergoes renal elimination, 10% by glomerular filtration and 90% by tubular secretion, mainly within the first hour. Significant concentrations occur in bile, but in patients with normal renal function only small amounts are excreted via the bile. Renal tubular secretion is inhibited by probenecid, which can be given to increase plasma-penicillin concentrations and prolong half-life.

Penicillin G Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Penicillin G Suppliers

Henan Qiande Pharmaceutical Co. LTD
Tel
19103869591
Email
1814581@qq.com
Country
China
ProdList
204
Advantage
58
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15839
Advantage
69
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Fax
021-64823266
Email
chenyj@titansci.com
Country
China
ProdList
14103
Advantage
59
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com
Country
China
ProdList
4552
Advantage
62
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
TargetMol Chemicals Inc.
Tel
021-021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7783
Advantage
58
Shanghai JONLN Reagent Co., Ltd.
Tel
400-0066400 13621662912
Fax
021-55660885
Email
422131432@qq.com
Country
China
ProdList
9978
Advantage
55
Hubei Jusheng Technology Co.,Ltd
Tel
027-59599241 18871490274
Fax
027-59599241
Email
1400878000@qq.com
Country
China
ProdList
9958
Advantage
58
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Alta Scientific Co., Ltd.
Tel
022-6537-8550 15522853686
Fax
022-2532-9655
Email
sales@altasci.com.cn
Country
China
ProdList
4511
Advantage
55
Shanghai Synchem Pharma Co., ltd
Tel
21-619849051-1 18521059765
Email
synchempharma@aliyun.com
Country
China
ProdList
6463
Advantage
55
Runze Pharmaceutical Suzhou Co., Ltd.
Tel
+86-512-62831367 13140980067
Fax
+86-512-62836800
Email
sales1@szrz.com.cn
Country
China
ProdList
37
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Hunan Waybel Advanced Materials Co.,Ltd
Tel
133-0845-3923 13319523173
Email
ivy@hnhbsj.com
Country
China
ProdList
456
Advantage
60
Shenzhen SUNGENING Bio-Medical Co., Ltd.
Tel
0755-28967200 13631290199
Fax
0755-28967200
Email
wxf@sungening.com
Country
China
ProdList
9577
Advantage
60
Aikon International Limited
Tel
025-66113011 18112977050
Fax
02557626880
Email
sales01@aikonchem.com
Country
China
ProdList
16027
Advantage
58
Wuhan FengyaoTonghui Chemical Products Co., Ltd.
Tel
027-87466105 15377573527
Email
2678564200@qq.com
Country
China
ProdList
17987
Advantage
58
PI & PI BIOTECH INC.
Tel
020-81716320 17788709170
Fax
020-81716319
Email
Sales@pipitech.com
Country
China
ProdList
2649
Advantage
58
Hubei Xinyuanshun Pharmaceutical Chemical Co., Ltd.
Tel
027-51831887 15337167856
Fax
027-51837635 QQ1165326703
Email
hubeixinyuanshun@163.com
Country
China
ProdList
10295
Advantage
58
Beijing OKA biological technology co., LTD
Tel
010-010-010-62971590 18548936886
Fax
010-62340519
Email
jack@oka-vip.com
Country
China
ProdList
6897
Advantage
58
ANHUI WITOP BIOTECH CO., LTD
Tel
+8615255079626
Email
eric@witopchemical.com
Country
China
ProdList
23541
Advantage
58
Hefei TNJ Chemical Industry Co.,Ltd.
Tel
+86-0551-65418671 +8618949823763
Fax
0551-65418697
Email
sales@tnjchem.com
Country
China
ProdList
34563
Advantage
58
Hebei Zhanyao Biotechnology Co. Ltd
Tel
15369953316 +8615369953316
Email
admin@zhanyaobio.com
Country
China
ProdList
2123
Advantage
58
Hubei Ipure Biology Co., Ltd
Tel
+8613367258412
Fax
18062427325
Email
ada@ipurechemical.com
Country
China
ProdList
10319
Advantage
58
Dayang Chem (Hangzhou) Co.,Ltd.
Tel
571-88938639 +8617705817739
Fax
+86-571-88938652,+86-571- 88492614
Email
info@dycnchem.com
Country
China
ProdList
52849
Advantage
58
AFINE CHEMICALS LIMITED
Tel
+86-0571-85134551
Fax
008657185134895
Email
sales@afinechem.com
Country
China
ProdList
15352
Advantage
58
Shaanxi Dideu Medichem Co. Ltd
Tel
+86-029-89586680 +86-18192503167
Fax
+86-29-88380327
Email
1026@dideu.com
Country
China
ProdList
7724
Advantage
58
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 17825480238
Fax
QQ 3008233717
Email
3008233717@qq.com
Country
China
ProdList
9919
Advantage
12
Career Henan Chemica Co
Tel
+86-0371-86658258 +8613203830695
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30240
Advantage
58
Hebei Binshare New Material Co. Ltd
Tel
+8618633865755
Email
china01@hbbinshare.com
Country
CHINA
ProdList
955
Advantage
58
Chemwill Asia Co.,Ltd.
Tel
86-21-51086038
Fax
86-21-51861608
Email
chemwill_asia@126.com
Country
CHINA
ProdList
23912
Advantage
58
Shanghai TenSus Biotechnology Co., Ltd.
Tel
021-50895067 18616507272
Fax
021-50895067
Email
tensus@163.com
Country
China
ProdList
4207
Advantage
58
Kunming jida pharmaceutical co. LTD
Tel
0871-68356968 13000000000
Fax
86-0871-6835699
Email
jidamd@jida.com.cn
Country
China
ProdList
12
Advantage
58
CONIER CHEM AND PHARMA LIMITED
Tel
+8618523575427
Email
sales@conier.com
Country
China
ProdList
49374
Advantage
58
Wuhan Yanzhe Technology Co., Ltd
Tel
15527250409
Fax
QQ:2692360204
Email
wenhaotian12@163.com
Country
China
ProdList
4495
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
13675144456
Fax
025-85563444
Email
sean.lv@synzest.com
Country
China
ProdList
10784
Advantage
58
DONBOO AMINO ACID COMPANY
Tel
+8613063595538
Email
donboo@donboo.com
Country
China
ProdList
9363
Advantage
58
Guangzhou Juntang Technology Co., Ltd
Tel
020-36607679 13502246435
Email
sales@dmstandards.com
Country
China
ProdList
10945
Advantage
58
Chengtian Fine Chemical Co., Ltd
Tel
18164098996
Fax
027-87680390
Email
3554657675@qq.com
Country
China
ProdList
6672
Advantage
58
Tianjin Guangfu Technology Development Co. LTD
Tel
022-022-85689490 13132141716
Email
2990156218@qq.com
Country
China
ProdList
1605
Advantage
58
Shaanxi Dideu Medichem Co. Ltd
Tel
029-61856358 15229202216
Fax
029-88380327
Email
1020@dideu.com
Country
China
ProdList
10007
Advantage
58
Foshan Treasure Biotechnology Co., Ltd
Tel
0757-85921206 18520245316
Email
2329783215@qq.com
Country
China
ProdList
12661
Advantage
58
JinOu Biomedical (Nanjing) Co., Ltd.
Tel
13000000000
Fax
jinoupharma@163
Email
jinoupharma@163.com
Country
China
ProdList
11721
Advantage
58
QUALITY CONTROL SOLUTIONS LTD.
Tel
0755-66853366; 13670046396
Email
ORDERS@QCSRM.COM
Country
China
ProdList
24326
Advantage
58
Wuhan Lvjing Fenghua Biotechnology Co., Ltd.
Tel
19972070065
Email
201746457@qq.com
Country
China
ProdList
6428
Advantage
58
Scinova Biotech(Guangzhou) Co., Ltd.
Tel
13268215580
Email
scinova_sales@163.com
Country
China
ProdList
7023
Advantage
58
Hebei ruqi technology co., ltd
Tel
176-03256889 17603256889
Email
1123722730@qq.com
Country
China
ProdList
3376
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81960175-877 18933936954
Email
tianwen.zhan@cato-chem.com
Country
China
ProdList
7735
Advantage
58
Hubei Wanye Zhongcheng Chemical Reagent Co., Ltd.
Tel
18671296875 18671296875
Email
1205035102@qq.com
Country
China
ProdList
4302
Advantage
58
More
Less

View Lastest Price from Penicillin G manufacturers

Career Henan Chemica Co
Product
Penicillin G 61-33-6
Price
US $0.37/KG
Min. Order
1KG
Purity
99%
Supply Ability
10kg/100kg
Release date
2020-11-09
Wuhan Boyuan Import & Export Co., LTD
Product
benzylpenicillin 61-33-6
Price
US $10.00-7.00/kg
Min. Order
1kg
Purity
99.60%
Supply Ability
50tons
Release date
2023-06-09
Wuhan Han Sheng New Material Technology Co.,Ltd
Product
Penicillin G 61-33-6
Price
US $0.00-0.00/g
Min. Order
100g
Purity
99%
Supply Ability
20 tons
Release date
2023-07-13

61-33-6, Penicillin GRelated Search:


  • PENICILLIN G K-SALT
  • PENICILLIN G POTASSIUM
  • (5r,6r)-benzylpenicillin
  • (phenylmethyl)-penicilli
  • (phenylmethyl)penicillin
  • (phenylmethyl)-penicillinicaci
  • cilloral
  • cilopen
  • compocilling
  • cosmopen
  • dropcillin
  • enylacetamido)-
  • freebenzylpenicillin
  • freepenicilling
  • freepenicillinii
  • galofak
  • gelacillin
  • henylacetamido)-
  • liquacillin
  • pencilling
  • pharmacillin
  • phenylacetamidopenicillanicacid
  • pradupen
  • 6-(2-phenylacetamido)penicillanic acid
  • (2S,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylicacid
  • BENZYLPENICILLIN
  • BENZYLPENICILLIN POTASSIUM
  • BENZYLPENICILLIN, K
  • BENZYLPENICILLIN POTASSIUM SALT
  • 4-Thia-1-azabicyclo3.2.0heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(phenylacetyl)amino- (2S,5R,6R)-
  • 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)- (8CI)
  • 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2α,5α,6β)]-
  • NSC 193396
  • Penicillin G (6CI)
  • Penicillin, (phenylmethyl)-
  • Penicillinic acid, (phenylmethyl)-
  • Phenylacetyl-6-aminopenicillanic acid
  • Penicillin(free,not its kalium salt)
  • Benzylpenicillin for system suitability
  • (phenylmethyl)penicillinicacid
  • 5alpha,6beta))-nylacetyl)amino)-(2s-(2alph
  • abbocillin
  • benzopenicillin
  • benzyl-6-aminopenicillinicacid
  • benzylpenicilling
  • benzyl-penicillinicaci
  • benzylpenicillinicacid
  • Specilline G
  • Ursopen
  • 3,3-DIMETHYL-4-THIA-1-AZABICYCLOHEPTANE-2-CARBOXYLICACID
  • (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
  • PENICILLIN G BASE
  • (6R)-6-(Phenylacetylamino)penicillanic acid
  • 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-
  • 99% Penicillin G 61-33-6 For Bactericidal Antibiotic
  • Penicillin G
  • Penicillin G USP/EP/BP
  • PENICILIN